Indikation: Männliche Stressharninkontinenz mit einer Restfunktion des äußeren Schließmuskels
Das ATOMS (Adjustable TransObturator Male System) ist ein einstellbares Langzeitimplantat zum Einmalgebrauch. Dieses hydraulische Schließmuskel-Kissen-System ersetzt die Funktion des Harnschließmuskels bei inkontinenten erwachsenen Männern.
[1] J. C. Angulo et al., “Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study,” World J. Urol., vol. 37, no. 10, pp. 2189–2197, Oct. 2019, doi: 10.1007/s00345-019-02639-4.
[2] J. C. Angulo, I. Arance, C. Esquinas, J. F. Dorado, J. P. Marcelino, and F. E. Martins, “Outcome Measures of Adjustable Transobturator Male System with Pre-attached Scrotal Port for Male Stress Urinary Incontinence After Radical Prostatectomy: A Prospective Study,” Adv. Ther., vol. 34, no. 5, pp. 1173–1183, May 2017, doi: 10.1007/s12325-017-0528-5.
[3] J. C. Angulo et al., “Results of Adjustable Trans-Obturator Male System in Patients with Prostate Cancer Treated with Prostatectomy and Radiotherapy: A Multicenter Study,” J. Clin. Med., vol. 12, no. 14, p. 4721, Jul. 2023, doi: 10.3390/jcm12144721.
[4] W. Bauer and C. Brössner, “Adjustable transobturator male system – ATOMS – for the treatment of postprostatectomy urinary incontinence: The surgical technique,” Pelviperineology, vol. 30, pp. 10–16, 2011,
[5] W. Bauer, M. Karik, and P. Schramek, “The self-anchoring transobturator male sling to treat stress urinary incontinence in men: A new sling, a surgical approach and anatomical fi ndings in a cadaveric study,” BJU Int., vol. 95, no. 9, pp. 1364–1366, 2005, doi: 10.1111/j.1464 410X.2005.05530.x.
[6] R. C. Doiron et al., “Canadian Experience with the Adjustable Transobturator Male System for Post- Prostatectomy Incontinence: A Multicenter Study,” J. Urol., vol. 202, no. 5, pp. 1022–1028, Nov. 2019, doi: 10.1097/JU.0000000000000420.
[7] J. F. Dorado and J. C. Angulo, “Refi ned Nomogram Incorporating Standing Cough Test Improves Prediction of Adjustable Trans-Obturator Male System (ATOMS) Success to Treat Post-Prostatectomy Male Stress Incontinence,” J. Pers. Med., vol. 12, no. 1, p. 94, Jan. 2022, doi: 10.3390/jpm12010094.
[8] C. Esquinas, I. Arance, J. Pamplona, A. Moraga, J. F. Dorado, and J. C. Angulo, “Tratamiento de la incontinencia urinaria de esfuerzo tras prostatectomía con el sistema masculino transobturador ajustable
(ATOMS®) con puerto escrotal premontado,” Actas Urológicas Españolas, vol. 42, no. 7, pp. 473–482, Sep. 2018, doi: 10.1016/j.acuro.2018.02.005.
[9] A. Friedl et al., “Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study,” BJU Int., vol. 119, no. 5, pp. 785–792, May 2017, doi: 10.1111/bju.13684.
[10] A. Friedl, W. Bauer, M. Rom, D. Kivaranovic, W. Lüftenegger, and C. Brössner, “Sexuality and erectile function after implantation of an Adjustable Transobturator Male System (ATOMS) for urinary stress
incontinence. A multi-institutional prospective study,” Arch. Ital. di Urol. e Androl., vol. 87, no. 4, p. 306, Jan. 2016, doi: 10.4081/aiua.2015.4.306.
[11] P. Geretto et al., “Comparison Study between Artifi cial Urinary Sphincter and Adjustable Male Sling: A Propensity-Score-Matched Analysis,” J. Clin. Med., vol. 12, no. 17, p. 5489, Aug. 2023, doi: 10.3390/
jcm12175489.
[12] A. Giammò and E. Ammirati, “Long-Term Survival Rate of ATOMS Implant for Male Stress Urinary Incontinence and Management of Late Complications,” J. Clin. Med., vol. 12, no. 6, p. 2296, Mar. 2023, doi: 10.3390/jcm12062296.
[13] S. Mühlstädt et al., “Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluation,” World J. Urol., vol. 35, no. 1, pp. 145–151, Jan. 2017, doi: 10.1007/s00345-016-1839-x.
[14] S. Mühlstädt et al., “An overview of the ATOMS generations: port types, functionality and risk factors,” World J. Urol., vol. 37, no. 8, pp. 1679–1686, Aug. 2019, doi: 10.1007/s00345-018-2548-4.
[15] F. Queissert et al., “ATOMS (Adjustable Transobturator Male System) Is an Effective and Safe Second- Line Treatment Option for Recurrent Urinary Incontinence after Implantation of an AdVance/ AdVance XP Fixed Male Sling? A Multicenter Cohort Analysis,” J. Clin. Med., vol. 11, no. 1, p. 81, Dec. 2021, doi: 10.3390/jcm11010081
[16] E. J. Redmond et al., “Multicentered Assessment of Clinical Outcomes and Factors Associated With Failure of the Adjustable TransObturator Male System (ATOMS),” Urology, vol. 148, pp. 280–286, Feb. 2021, doi: 10.1016/j.urology.2020.09.045.
[17] A. Ullate et al., “ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture,” J. Clin. Med., vol. 11, no. 16, p. 4882, Aug. 2022, doi: 10.3390/jcm11164882.
Das Silikonkissen von ATOMS übt Druck auf den M. bulbospongiosus und damit auf die Harnröhre aus. Diese Kompression reduziert den unwillkürlichen Urinverlust und erleichtert gleichzeitig die physiologische Kontraktion, die das absichtliche Urinieren bewirkt.
Die Schlinge ist selbstverankernd und die symmetrische Positionierung des Kissens unterhalb der Harnröhre wird durch eine 4-Punkt-Fixierung erreicht. Die integrierten Netzarme werden um den Ramus pubicus inferior bis zur Mitte des Implantats zurückgezogen, um das System zu fixieren.
Der angebrachte Port wird im Skrotum positioniert. Über den Port ist das Füllvolumen des Kissens und damit die Kompression auf den M. bulbospongiosus einstellbar. Das Füllvolumen wird vom Chirurgen mit einer nicht-bohrenden Portnadel eingestellt und hängt von der Anatomie und den Bedürfnissen des Patienten ab.
